1. Home
  2. CBAT vs NSPR Comparison

CBAT vs NSPR Comparison

Compare CBAT & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBAK Energy Technology Inc.

CBAT

CBAK Energy Technology Inc.

HOLD

Current Price

$0.80

Market Cap

70.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.00

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBAT
NSPR
Founded
1999
2005
Country
China
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
72.1M
IPO Year
2006
2009

Fundamental Metrics

Financial Performance
Metric
CBAT
NSPR
Price
$0.80
$1.00
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
108.2K
290.7K
Earning Date
05-18-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$195,189,306.00
$2,310,000.00
Revenue This Year
$66.88
$57.98
Revenue Next Year
$41.54
$95.41
P/E Ratio
N/A
N/A
Revenue Growth
10.52
N/A
52 Week Low
$0.70
$0.86
52 Week High
$1.25
$2.93

Technical Indicators

Market Signals
Indicator
CBAT
NSPR
Relative Strength Index (RSI) 48.66 39.86
Support Level $0.78 N/A
Resistance Level $0.93 $1.29
Average True Range (ATR) 0.04 0.07
MACD 0.01 0.00
Stochastic Oscillator 46.86 33.93

Price Performance

Historical Comparison
CBAT
NSPR

About CBAT CBAK Energy Technology Inc.

CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments; CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe, India, Africa, and other regions.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: